211 related articles for article (PubMed ID: 22436404)
1. Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection.
Friedman-Levi Y; Hoftberger R; Budka H; Mayer-Sonnenfeld T; Abramsky O; Ovadia H; Gabizon R
J Neuroinflammation; 2012 Mar; 9():58. PubMed ID: 22436404
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system.
Gourdain P; Ballerini C; Nicot AB; Carnaud C
J Neuroinflammation; 2012 Jan; 9():25. PubMed ID: 22281016
[TBL] [Abstract][Full Text] [Related]
3. Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis.
Friedman-Levi Y; Ovadia H; Hoftberger R; Einstein O; Abramsky O; Budka H; Gabizon R
J Virol; 2007 Sep; 81(18):9942-9. PubMed ID: 17626090
[TBL] [Abstract][Full Text] [Related]
4. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.
Krasemann S; Neumann M; Szalay B; Stocking C; Glatzel M
J Gen Virol; 2013 Feb; 94(Pt 2):453-463. PubMed ID: 23136363
[TBL] [Abstract][Full Text] [Related]
5. Genetic prion disease: no role for the immune system in disease pathogenesis?
Friedman-Levi Y; Binyamin O; Frid K; Ovadia H; Gabizon R
Hum Mol Genet; 2014 Aug; 23(15):4134-41. PubMed ID: 24667414
[TBL] [Abstract][Full Text] [Related]
6. Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.
Krasemann S; Neumann M; Luepke JP; Grashorn J; Wurr S; Stocking C; Glatzel M
Acta Neuropathol; 2012 Jul; 124(1):111-26. PubMed ID: 22271154
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
8. Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice.
Tal Y; Souan L; Cohen IR; Meiner Z; Taraboulos A; Mor F
J Neurosci Res; 2003 Jan; 71(2):286-90. PubMed ID: 12503092
[TBL] [Abstract][Full Text] [Related]
9. Subclinical prion disease induced by oral inoculation.
Thackray AM; Klein MA; Bujdoso R
J Virol; 2003 Jul; 77(14):7991-8. PubMed ID: 12829838
[TBL] [Abstract][Full Text] [Related]
10. Infection with Mycobacterium bovis BCG diverts traffic of myelin oligodendroglial glycoprotein autoantigen-specific T cells away from the central nervous system and ameliorates experimental autoimmune encephalomyelitis.
Sewell DL; Reinke EK; Co DO; Hogan LH; Fritz RB; Sandor M; Fabry Z
Clin Diagn Lab Immunol; 2003 Jul; 10(4):564-72. PubMed ID: 12853387
[TBL] [Abstract][Full Text] [Related]
11. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
Zheng H; Zhang H; Liu F; Qi Y; Jiang H
Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
[TBL] [Abstract][Full Text] [Related]
12. The pathogenic mechanisms of prion diseases.
Unterberger U; Voigtländer T
CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):424-55. PubMed ID: 18220781
[TBL] [Abstract][Full Text] [Related]
13. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
14. Active Induction of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice.
Contarini G; Giusti P; Skaper SD
Methods Mol Biol; 2018; 1727():353-360. PubMed ID: 29222794
[TBL] [Abstract][Full Text] [Related]
15. Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.
Sacquin A; Chaigneau T; Defaweux V; Adam M; Schneider B; Bruley Rosset M; Eloit M
Brain Behav Immun; 2012 Aug; 26(6):919-30. PubMed ID: 22522067
[TBL] [Abstract][Full Text] [Related]
16. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
17. The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity.
Hetz C; Russelakis-Carneiro M; Wälchli S; Carboni S; Vial-Knecht E; Maundrell K; Castilla J; Soto C
J Neurosci; 2005 Mar; 25(11):2793-802. PubMed ID: 15772339
[TBL] [Abstract][Full Text] [Related]
18. Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Theotokis P; Touloumi O; Lagoudaki R; Nousiopoulou E; Kesidou E; Siafis S; Tselios T; Lourbopoulos A; Karacostas D; Grigoriadis N; Simeonidou C
J Neuroinflammation; 2016 Oct; 13(1):265. PubMed ID: 27724971
[TBL] [Abstract][Full Text] [Related]
19. Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis.
Kivisäkk P; Imitola J; Rasmussen S; Elyaman W; Zhu B; Ransohoff RM; Khoury SJ
Ann Neurol; 2009 Apr; 65(4):457-69. PubMed ID: 18496841
[TBL] [Abstract][Full Text] [Related]
20. Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
Zanucoli F; Thomé R; Bonfanti AP; de Carvalho AC; Issayama LK; da Costa TA; Di Gangi R; Ferreira IT; Bombeiro AL; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2014 Dec; 20(12):1061-4. PubMed ID: 25417930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
